TMC Life Sciences Berhad (KLSE:TMCLIFE)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.505
0.00 (0.00%)
At close: Apr 27, 2026
13.48%
Market Cap 888.36M
Revenue (ttm) 387.22M
Net Income (ttm) 12.59M
Shares Out 1.74B
EPS (ttm) 0.01
PE Ratio 70.57
Forward PE n/a
Dividend 0.00 (0.37%)
Ex-Dividend Date Dec 8, 2025
Volume 63,400
Average Volume 118,555
Open 0.505
Previous Close 0.505
Day's Range 0.505 - 0.510
52-Week Range 0.380 - 0.575
Beta 0.40
RSI 57.60
Earnings Date May 22, 2026

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1994
Country Malaysia
Stock Exchange Bursa Malaysia
Ticker Symbol TMCLIFE
Full Company Profile

Financial Performance

In fiscal year 2025, TMC Life Sciences Berhad's revenue was 345.63 million, a decrease of -0.23% compared to the previous year's 346.42 million. Earnings were 3.61 million, a decrease of -91.13%.

Financial Statements

News

There is no news available yet.